Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT03333811
Other study ID # IRB00036987
Secondary ID
Status Not yet recruiting
Phase N/A
First received November 2, 2017
Last updated January 3, 2018
Start date February 2018
Est. completion date June 2018

Study information

Verified date November 2017
Source Wake Forest University Health Sciences
Contact Candace Parker-Autry, MD
Phone 336-716-3779
Email cparkera@wakehealth.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to determine if perineorrhaphy performed with surgical vaginal prolapse repair improves sexual function.


Description:

The decision to include perineorrhaphy into vaginal prolapse repair is made solely on surgeon preference and personal experience. Little research has been done to explore the short-term and long-term post-operative consequences of perineorrhaphy. This study will explore the effects of perineorrhaphy on post-op sexual function.

Subjects will be randomized to receive a perineorrhaphy in conjunction with their surgical vaginal prolapse repair or to have the surgical repair performed without a perineorrhaphy. At the 6-8 week post op visit, subjects will be asked questions about the presence of genital pain. Subjects will then be given validated symptom and quality of life study questionnaires at 6 and 12 month post op visits to assess sexual function.

Subject partners will be invited to participate after the participant has finalized informed consent. If partner decides to participate, they will complete the a partner questionnaire.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 65
Est. completion date June 2018
Est. primary completion date February 2018
Accepts healthy volunteers No
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Diagnosed with vaginal prolapse to include either apical vaginal prolapse (uterovaginal or vaginal vault), anterior vaginal prolapse, or posterior vaginal prolapse

- Genital hiatus with strain =4 cm, =6 cm measured via standard POPQ examination

- Participates in heterosexual activity at least once/3 months OR desires to be sexually active but limits activity because of prolapse symptoms

- Desires to retain functional vagina (no obliterative procedures)

- Total vaginal length =7 cm

- Scheduled for native tissue vaginal repair of prolapse

- Agreeable to use of vaginal estrogen cream throughout the study period (12 months)

Exclusion Criteria:

- Genital hiatus measured to be >6cm with maximum Valsalva

- Absence of perineal body as measured by PB measurement on POPQ examination of <0.5cm

- Diagnosed with external anal sphincter separation on endoanal ultrasound

- Diagnosed with total procidentia (Stage IV prolapse)

- Obliterative vaginal procedure scheduled

- Atrophic vaginal epithelium AND unable to use intravaginal estrogen

- History of chronic pelvic pain/Interstitial cystitis

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Perineorrhaphy
Perineorrhaphy is a surgical procedure that aims to re-approximate the disrupted pelvic floor muscles and connective tissue to the midline
Surgical repair of vaginal prolapse
Surgical correction of Vaginal prolapse

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Wake Forest University Health Sciences

References & Publications (4)

Kahn MA, Stanton SL. Posterior colporrhaphy: its effects on bowel and sexual function. Br J Obstet Gynaecol. 1997 Jan;104(1):82-6. — View Citation

Pauls RN, Silva WA, Rooney CM, Siddighi S, Kleeman SD, Dryfhout V, Karram MM. Sexual function after vaginal surgery for pelvic organ prolapse and urinary incontinence. Am J Obstet Gynecol. 2007 Dec;197(6):622.e1-7. — View Citation

Schimpf MO, Harvie HS, Omotosho TB, Epstein LB, Jean-Michel M, Olivera CK, Rooney KE, Balgobin S, Ibeanu OA, Gala RB, Rogers RG; Society of Gynecologic Surgeons Fellows' Pelvic Research Network. Does vaginal size impact sexual activity and function? Int Urogynecol J. 2010 Apr;21(4):447-52. doi: 10.1007/s00192-009-1051-2. Epub 2009 Dec 4. — View Citation

Weber AM, Walters MD, Piedmonte MR. Sexual function and vaginal anatomy in women before and after surgery for pelvic organ prolapse and urinary incontinence. Am J Obstet Gynecol. 2000 Jun;182(6):1610-5. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Change in sexual function in women who have perineorrhaphy compared to those without perineorrhaphy concomitantly with vaginal repair of prolapse Female Sexual Function Index (FSFI) is a questionnaire design to measure sexual function in women by assessing the domains of sexual arousal, sexual desire, lubrication, orgasm, satisfaction, and pain. Each question is scored on a scale of 1 to 5; 1 indicating the highest level of difficulty and lowest level of frequency/intensity, and 5 indicating the lowest level of difficulty, and highest possible frequency. A score of zero for a question indicates no sexual activity. The FSFI comes with a scale that provides a domain factor to multiply the sum of the domain scores. Each domain score is then added up for a participants total score with 36 being the maximum and 2.0 being the minimum. 3 months, 6 months, 12 months
Secondary recurrence rate of pelvic organ prolapse 12 month
Secondary cross-sectional analysis vaginal introital caliber versus PISQ scores evaluate the relationship between vaginal introital caliber and the presence of sexual dysfunction in a cross-sectional analysis. The PISQ is the Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire designed to evaluate sexual function in women with pelvic organ prolapse and/or urinary incontinence. 12 month
Secondary Prolapse Questionnaire The PFDI-20 includes 20 questions and 3 scales. Each of the 3 scales is scored from 0 (least distress) to 100 (greatest distress). The sum of the scores of these 3 scales serves as the overall summary score of the PFDI-20 and ranges from 0 - 300. The 3 scales include questions taken from the following widely used outcome measures: Urinary Distress Inventory - 6 questions, Pelvic Organ Prolapse Distress Inventory - 6 questions, and Colorectal-Anal Distress Inventory - 8 questions 12 month
Secondary Pain Assessment Pain Questionnaire is a one question questionnaire that asks subjects to answer yes or no if they experience genital pain. If yes, the subject will then provide an answer to how much the pain bothers them using 4 options; Not at all, Somewhat, Moderately, and Quite a bit. 8 weeks
Secondary Partner Erectile Function Participant partners will be invited to participate by providing answers to the IIEF, the International Index of Erectile Function. The IIEF examines the 4 main domains of male sexual function: erectile function, orgasmic function, sexual desire, and intercourse satisfaction. A score of 0-5 is given to each question with 0 indicating no sexual activity, 1 indicating the least amount of frequency/satisfaction, and 5 indicating the highest amount of satisfaction/frequency. 12 months
See also
  Status Clinical Trial Phase
Recruiting NCT04701047 - Prospective Observational Prolapse Study
Recruiting NCT03664986 - Pudendal Block Using Liposomal Bupivacaine vs. Standard Treatment During Sacrospinous Ligament Fixation Phase 4
Completed NCT00388947 - Observational Data Collection of Surgical Outcomes in the Treatment of Vaginal Prolapse With AMS Products N/A
Active, not recruiting NCT00442247 - A Randomised, Controlled Study of Bimesh, Pelvicol for Vaginal Wall Prolapse N/A
Not yet recruiting NCT04078802 - 0050-19-RMB CTIL - VNOTES Compared to VH for Vaginal Apex Prolapse N/A
Recruiting NCT00918099 - The Use of Avaulta for Anterior Repair N/A
Completed NCT00769054 - Local Infiltration Analgesia With Ropivacaine in Posterior Vaginal Wall Prolapse:a Randomized, Double-Blind Study Phase 4
Completed NCT03187574 - Comparison of Two Vaginal Mesh Kits in the Management of Vaginal Prolapse N/A
Completed NCT00679276 - Treatment Outcomes of Vaginal Prolapse Repair N/A
Completed NCT03338400 - Dexamethasone Administration To Improve Patient Recovery In Ambulatory Vaginal Prolapse Surgery: Is There A Role? Phase 2
Completed NCT00153231 - Posterior IVS Versus Sacrospinous Suspension in Vaginal Vault Prolapse Repair Phase 4
Completed NCT01409902 - Using a Sheathed Speculum to Visualize and Access the Cervix In Women With Excessive Vaginal Tissue N/A
Completed NCT00557882 - Efficacy Study of Vaginal Mesh for Anterior Prolapse Phase 4
Completed NCT00196495 - Clinical Assessment of the Total Vaginal Mesh Technique for Treatment of Genital Prolapse Phase 4
Not yet recruiting NCT06234449 - The Impact of Long-term Pessary Use on Pelvic Organ Prolapse oìduring Covid-19 Pandemic in Patients Attending Surgery
Active, not recruiting NCT03658395 - Sacrocolpopexy With Posterior Repair Obstructed Defecation Symptoms N/A
Recruiting NCT05449054 - Continuous Stitches Versus Simple Interrupted Stitches for Anterior Colporrhaphy N/A
Completed NCT00475540 - Efficacy Study of Vaginal Mesh for Prolapse N/A
Enrolling by invitation NCT00571350 - Anterior Vaginal Wall Reconstruction Phase 1/Phase 2
Completed NCT02431897 - Investigation to Minimize Prolapse Recurrence of the Vagina Using Estrogen Phase 4